Recursion is at the leading edge of applying AI and ML to drug development. The company exemplifies a new wave of “techbio” companies, that tightly couple compute and robotics with biology and chemistry. The task of decoding biology requires vast amounts of biological data and innovative strategies to make use of that data. It also The post Biotech Special: ML at Recursion with Jordan Christensen and Imran Haque appeared first on Software Engineering Daily.